| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 5.10 | 0.07 (+1.39%) | 3.45 - 6.15 | 33.8 thousand (Above Avg) |
Market data as of 10:54AM 05/23/13. Quotes are delayed by at least 15 min.
| Open | 5.00 |
|---|---|
| Previous Close | 5.03 |
| Day's Range | 4.96 - 5.10 |
| Market Cap | 153.3M |
| Avg Volume (10 Day) | 80.5K |
| Price/Earnings (Trailing 12 Mo.) | 62.9x |
| Earnings Per Share (Trailing 12 Mo.) | 0.08 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
No news headlines available for HBIO
| HBIO | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -1.75% | |
| Net Income Growth (1yr) | -52.41% | |
| Total Debt/Equity | 0.14 | |
| LT Debt/Equity | 0.11 | |
| Earnings Yield | 1.59% | |
| Price/Sales | 1.39 |
| Company | Last | Change |
|---|---|---|
| BIOLASE Inc | 4.70 | -4.86% |
| IMRIS Inc | 2.57 | -2.28% |
| Rochester Medical Corp | 14.58 | -0.21% |
| Utah Medical Products Inc | 47.79 | -1.68% |
| Nanosphere Inc | 3.73 | +0.81% |
Data is delayed by at least 15 min.